Tiflamizole
Tiflamizole
Tiflamizole is a chemical compound that has been studied for its potential use in medical applications, particularly as an antifungal agent. This article provides a comprehensive overview of tiflamizole, including its chemical properties, mechanism of action, clinical applications, and research developments.
Chemical Properties[edit | edit source]
Tiflamizole is classified as an imidazole derivative, which is a class of compounds known for their antifungal properties. The chemical structure of tiflamizole includes an imidazole ring, which is crucial for its biological activity. The molecular formula of tiflamizole is C₁₃H₁₁Cl₂N₃, and it has a molecular weight of 280.15 g/mol.
Mechanism of Action[edit | edit source]
Tiflamizole exerts its antifungal effects by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. By disrupting ergosterol production, tiflamizole compromises the integrity of the fungal cell membrane, leading to cell lysis and death. This mechanism is similar to other imidazole antifungals, such as ketoconazole and miconazole.
Clinical Applications[edit | edit source]
While tiflamizole has shown promise in preclinical studies, its clinical applications are still under investigation. It has been primarily studied for the treatment of superficial fungal infections, such as dermatophytosis and candidiasis. However, further clinical trials are necessary to establish its efficacy and safety profile in humans.
Research and Development[edit | edit source]
Research on tiflamizole is ongoing, with studies focusing on its pharmacokinetics, optimal dosing regimens, and potential side effects. Recent advancements in drug delivery systems, such as liposomal formulations, are being explored to enhance the bioavailability and therapeutic efficacy of tiflamizole.
Safety and Side Effects[edit | edit source]
As with many antifungal agents, potential side effects of tiflamizole include skin irritation, gastrointestinal disturbances, and allergic reactions. Long-term safety data are limited, and further studies are needed to fully understand the risk profile of tiflamizole.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
